KABI на Английском - Английский перевод

• kabi
• cubby

Примеры использования Kabi на Хорватском языке и их переводы на Английский язык

Zdravo, Vajate!- Zdravo, Kabi.
Hey, Wyatt. Hey, Cubby.

Kabi od Ujedinjeno Kraljevstvo.
Kabi from United Kingdom.

Kako primjenjivati DOCETAXEL KABI.
How to use docetaxel kabi.

DOCETAXEL KABI koncentrat za otopinu za infuziju je bistra, bezbojna do blijedo žuta otopina.
DOCETAXEL KABI concentrate for solution for infusion is a clear, colourless to pale yellow solution.

Ja i Dzef mislimo da je besmisleno dacekamo- Zdravo, Kabi.
Me and Jeff don't think there's much point hanging out. Hey, Cubby.

Za liječenje karcinoma pluća DOCETAXEL KABI se primjenjuje sam ili u kombinaciji s cisplatinom.
For the treatment of lung cancer, DOCETAXEL KABI could be administered either alone or in combination with cisplatin.

DOCETAXEL KABI je u kombinaciji s doksorubicinom i ciklofosfamidom indiciran za adjuvantno liječenje bolesnika s.
DOCETAXEL KABI in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with.

Opis odabranih nuspojava kod karcinoma dojke za DOCETAXEL KABI 100 mg/m² u kombinaciji s trastuzumabom.
Description of selected adverse reactions in breast cancer for DOCETAXEL KABI 100 mg/m² in combination with trastuzumab.

Pemetrexed Fresenius Kabi se također primjenjuje u kombinaciji s cisplatinom za početno liječenje bolesnika s uznapredovalim stadijem raka pluća.
Pemetrexed Fresenius Kabi is also given in combination with cisplatin for the initial treatment of patients with advanced stage of lung cancer.

Za liječenje metastatskog karcinoma želuca DOCETAXEL KABI se primjenjuje u kombinaciji s cisplatinom i 5-fluorouracilom.
For the treatment of metastatic gastric cancer, DOCETAXEL KABI is administered in combination with cisplatin and 5-fluorouracil.

Busulfan Fresenius Kabi se sastoji od koncentrata za otopinu za infuziju i isporučuje se u bezbojnim staklenim bočicama, svaka bočica sadrži 60 mg busulfana.
Busulfan Fresenius Kabi consists of a concentrate for solution for infusion and is supplied in colourless glass vials, each vial containing 60 mg of busulfan.

Za liječenje karcinoma glave i vrata DOCETAXEL KABI se primjenjuje u kombinaciji s cisplatinom i 5-fluorouracilom.
For the treatment of head and neck cancer, DOCETAXEL KABI is administered in combination with cisplatin and 5-fluorouracil.

Kompanija Fresenius Kabi je globalna kompanija za zdravstvenu zaštitu specijalizirana za spasonosne lijekove i tehnologije za infuziju, transfuziju i kliničku prehranu.
Company Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.

U odraslih bolesnika podobnih za kondicionirano doziranje smanjenog intenziteta, lijek Busulfan Fresenius Kabi daje se odmah nakon liječenja drugim lijekom, fludarabinom.
In adult patients who are eligible for a‘reduced-intensity' conditioning regimen, Busulfan Fresenius Kabi is given right after treatment with another medicine, fludarabine.

Opis odabranih nuspojava za DOCETAXEL KABI 75 mg/m² u kombinaciji s cisplatinom i5- fluorouracilom u terapiji adenokarcinoma želuca.
Description of selected adverse reactions in gastric adenocarcinoma cancer for DOCETAXEL KABI 75 mg/m2 in combination with cisplatin and 5-fluorouracil.

Liječnik će Vam propisati tablete steroida(ekvivalentne dozi deksametazona od 4 miligrama dvaput na dan) koje ćete morati uzeti dan prije, na sam dan i dan nakon primjene lijeka Pemetrexed Fresenius Kabi.
Your doctor will prescribe you steroid tablets(equivalent to 4 milligram of dexamethasone twice a day) that you will need to take on the day before, on the day of, and the day after Pemetrexed Fresenius Kabi treatment.

Za liječenje karcinoma prostate DOCETAXEL KABI se primjenjuje u kombinaciji s prednizonom ili prednizolonom.
For the treatment of prostate cancer, DOCETAXEL KABI is administered in combination with prednisone or prednisolone.

Fresenius Kabi ulazi na tržište farmaceutskih proizvoda u Sjevernoj Americi i postaje vodeći svjetski dobavljač u području generičkih lijekova za intravensku primjenu akvizicijom društva APP Pharmaceuticals sa sjedištem u SAD-u.
Fresenius Kabi enters the North American pharmaceuticals market and becomes a globally leading supplier in the field of intravenously administered generic drugs via the acquisition of the U.S. based APP Pharmaceuticals.

Za liječenje uznapredovalog karcinoma dojke, DOCETAXEL KABI Ese primjenjuje sam ili u kombinaciji s doksorubicinom, trastuzumabom ili kapecitabinom.
For the treatment of advanced breast cancer, DOCETAXEL KABI could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.

Fresenius Kabi akvizicijom društva za transfuzijsku tehnologiju Fenwal postaje svjetski lider u transfuzijskoj tehnologiji sa širokim portfeljem proizvoda za prikupljanje i preradu krvnih sastojaka te za liječenje krvi bolesnika pomoću sustava afereze.
Fresenius Kabi acquires the transfusion technology company Fenwal and creates a global leader in transfusion technology with a broad product portfolio for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.

Za pripremu konačne otopine za infuziju, dodajte(A) ml lijeka Busulfan Fresenius Kabi u(B) ml otapala otopina natrijeva klorida 9 mg/ml(0,9%) za injekciju ili 5%-tne otopine glukoze za injekciju.
To prepare the final solution for infusion, add(A) ml of Busulfan Fresenius Kabi to(B) ml of diluent sodium chloride 9 mg/ml(0.9%) solution for injection or glucose solution for injection 5.

Kompanija Fresenius Kabi specijalizirana je u području onkoloških pripravaka uz integriranu proizvodnu, regulatornu, prodajnu, marketinšku i distribucijsku podršku.
Fresenius Kabi is specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing and distribution set up.

Obavijest o ponovnom stavljanju u promet serija 15HK211F2 i 15HL218F1 lijeka Ciprofloxacin Kabi 400 mg/200 ml otopina za infuziju i serije 15IB515P2 lijeka Ciprofloxacin Kabi 200 mg/100 ml otopina za infuziju- Novosti| Novosti i edukacije.
Notice on reinstatement of batches 15HK211F2 and 15HL218F1 of Ciprofloxacin Kabi 400 mg/200 ml solution for infusion and batch 15IB515P2 of Ciprofloxacin Kabi 200 mg/100 ml solution for infusion- News| News and Educations.

Pemetrexed Fresenius Kabi je indiciran kao monoterapija u terapiji održavanja lokalno uznapredovalog ili metastatskog raka pluća nemalih stanica kod kojeg histološki ne prevladavaju pločaste stanice u bolesnika u kojih bolest nije napredovala neposredno nakon kemoterapije na bazi platine vidjeti dio 5.1.
Pemetrexed Fresenius Kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy see section 5.1.

U sklopu transfuzijskih tehnologija Fresenius Kabi nudi proizvode za prikupljanje i preradu krvnih sastojaka te za liječenje krvi pacijenata putem sustava afereze.
Within transfusion technologies, Fresenius Kabi provides products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.

Pemetrexed Fresenius Kabi je u kombinaciji s cisplatinom indiciran za liječenje bolesnika s neoperabilnim malignim pleuralnim mezoteliomom koji prethodno nisu primali kemoterapiju.
Pemetrexed Fresenius Kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.

Obavijest o privremenoj obustavi distribucije i primjene serija 15HK211F2 i 15HL218F1 lijeka Ciprofloxacin Kabi 400 mg/200 ml otopina za infuziju i serije 15IB515P2 lijeka Ciprofloxacin Kabi 200 mg/100 ml otopina za infuziju- Novi podaci o sigurnoj primjeni lijekova| Farmakovigilancija.: HALMED.
Notice on temporary discontinuation of supply chain and use of batches 15HK11F2 and 15HL218F1 of Ciprofloxacin Kabi 400 mg/200 ml solution for infusion and batches 15IB15P2 of Ciprofloxacin Kabi 200 mg/100 ml solution for infusion.- New Safety Information| Pharmacovigilance.: HALMED.

Busulfan Fresenius Kabi se ne smije unositi u intravensku vrećicu koja ne sadrži otopinu natrijeva klorida 9 mg/ml(0,9%) za injekciju ili 5%-tnu otopinu glukoze za injekciju.
Busulfan Fresenius Kabi must not be put into an intravenous bag that does not contain sodium chloride 9 mg/ml(0.9%) solution for injection or glucose solution for injection 5.

Obavijest o privremenoj obustavi distribucije i primjene serija 15HK211F2 i 15HL218F1 lijeka Ciprofloxacin Kabi 400 mg/200 ml otopina za infuziju i serije 15IB515P2 lijeka Ciprofloxacin Kabi 200 mg/100 ml otopina za infuziju- Novi podaci o sigurnoj primjeni lijekova| Farmakovigilancija.: HALMED FAQ.
Notice on temporary discontinuation of supply chain and use of batches 15HK11F2 and 15HL218F1 of Ciprofloxacin Kabi 400 mg/200 ml solution for infusion and batches 15IB15P2 of Ciprofloxacin Kabi 200 mg/100 ml solution for infusion.- News- Inspection| Distribution, Manufacturing and Inspection.: HALMED.

Pemetrexed Fresenius Kabi Vam se može propisati ako imate rak pluća u uznapredovalom stadiju i ako je Vaša bolest reagirala na liječenje ili ostala uglavnom nepromijenjena nakon početne kemoterapije.
Pemetrexed Fresenius Kabi can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy.